Effect of gambisan on the inhibition of adipogenesis in 3T3-L1 adipocytes

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Kang, Jung Won ^a   Nam, Dongwoo ^a   Kim, Kun Hyung ^a   Huh, Jeong Eun ^a   Lee, Jae Dong ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ATRACTYLODES EXTRACT; CAFFEINE; CCAAT ENHANCER BINDING PROTEIN ALPHA; DNA; DYE; EPHEDRA INTERMEDIA EXTRACT; EPHEDRINE; EPIGALLOCATECHIN GALLATE; GAMBISAN; LACTATE DEHYDROGENASE; LIPID; LIPOPROTEIN LIPASE; MESSENGER RNA; OIL RED O; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THEA SINENSIS EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; ATRACTYLODES; ATRACTYLODES LANCEA; CAMELLIA SINENSIS; CELL DIFFERENTIATION; CELL STRAIN 3T3; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG SCREENING; ENZYME ASSAY; EPHEDRA; EPHEDRA INTERMEDIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID STORAGE; MEDICINAL PLANT; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

EID: 84884214309     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/789067     Document Type: Article

References (36)

1. Kopelman P. G., Obesity as a medical problem. Nature 2000 404 6778 635 643 2-s2.0-0034611791
2. Yanovski S. Z., Yanovski J. A., Obesity. New England Journal of Medicine 2002 346 8 591 602 2-s2.0-0037148922 10.1056/NEJMra012586
3. Hong Y., Kim M., Yoon M., The anti-angiogenic herbal extracts Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris suppresses adipogenesis in 3T3-L1 adipocytes. Pharmaceutical Biology 2011 49 8 775 783 2-s2.0-79959615398 10.3109/13880209.2010.547208
4. Frühbeck G., Gómez-Ambrosi J., Muruzábal F. J., Burrell M. A., The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology-Endocrinology and Metabolism 2001 280 6 E827 E847 2-s2.0-0034987715
5. Lin J., Della-Fera M. A., Baile C. A., Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obesity Research 2005 13 6 982 990 2-s2.0-26944480126
6. Huntington M. K., Shewmake R. A., Behavioral and medical management of obesity. South Dakota Medicine 2011 51 55 2-s2.0-79960978720
7. Burke L. E., Wang J., Treatment strategies for overweight and obesity. Journal of Nursing Scholarship 2011 43 4 368 375
8. Cooke D., Bloom S., The obesity pipeline: current strategies in the development of anti-obesity drugs. Nature Reviews Drug Discovery 2006 5 11 919 931 2-s2.0-33750510903 10.1038/nrd2136
9. Derosa G., Maffioli P., Anti-obesity drugs: a review about their effects and their safety. Expert Opinion on Drug Safety 2012 11 3 459 471 2-s2.0-84860163107 10.1517/14740338.2012.675326
10. Kim C. K., Kim M., Oh S. D., Lee S., Sun B., Choi G. S., Kim S., Bae H., Kang C., Min B., Effects of Atractylodes macrocephala Koidzumi rhizome on 3T3-L1 adipogenesis and an animal model of obesity. Journal of Ethnopharmacology 2011 137 1 396 402 2-s2.0-80052038402 10.1016/j.jep.2011.05.036
11. Wang Y., Deng M., Zhang S., Zhou Z., Tian W., Parasitic loranthus from Loranthaceae rather than Viscaceae potently inhibits fatty acid synthase and reduces body weight in mice. Journal of Ethnopharmacology 2008 118 3 473 478 2-s2.0-47749109824 10.1016/j.jep.2008.05.016
12. Guo A. J., Choi R. C., Cheung A. W., Li J., Chen I. X., Dong T. T., Tsim K. W., Lau B. W., Stimulation of Apolipoprotein A-IV expression in Caco-2/TC7 enterocytes and reduction of triglyceride formation in 3T3-L1 adipocytes by potential anti-obesity Chinese herbal medicines. Chinese Medicine 2009 4 5 2-s2.0-65749104792 10.1186/1749-8546-4-5
13. Jeong S., Chae K., Jung Y. S., Rho Y. H., Lee J., Ha J., Yoon K. H., Kim G. C., Oh K. S., Shin S. S., Yoon M., The Korean traditional medicine Gyeongshingangjeehwan inhibits obesity through the regulation of leptin and PPAR α action in OLETF rats. Journal of Ethnopharmacology 2008 119 2 245 251 2-s2.0-50949084007 10.1016/j.jep.2008.06.037
14. Lee H., Kang R., Yoon Y., SH21B, an anti-obesity herbal composition, inhibits fat accumulation in 3T3-L1 adipocytes and high fat diet-induced obese mice through the modulation of the adipogenesis pathway. Journal of Ethnopharmacology 2010 127 3 709 717 2-s2.0-76149093513 10.1016/j.jep.2009.12. 002
15. Park S., Lee J. B., Daily J. W., Anti-obesity effects of Chang-Chul-Eui-Ee-In-Tang [see text] in female rats with diet-induced obesity. Chinese Journal of Integrative Medicine 2011 17 12 925 932 2-s2.0-84859921648
16. Park C. H., Jeong S. J., Lee H. J., Lee E. O., Bae H., Lee M., Kim S., Jung H., Ahn K. S., Kim S., Traditional medicine Taeeumjowitangkagambang exerts antiobesity and hypolipidemic effects via antioxidant enzyme enhancement. Phytotherapy Research 2010 24 11 1700 1709 2-s2.0-78049415813 10.1002/ptr.3179
17. Schmitt G. C., Arbo M. D., Lorensi A. L., Maciel E. S., Krahn C. L., Mariotti K. C., Dallegrave E., Leal M. B., Limberger R. P., Toxicological effects of a mixture used in weight loss products: p-synephrine associated with ephedrine, salicin, and caffeine. International Journal of Toxicology 2012 31 2 184 191
18. Nakabayashi H., Hashimoto T., Ashida H., Nishiumi S., Kanazawa K., Inhibitory effects of caffeine and its metabolites on intracellular lipid accumulation in murine 3T3-L1 adipocytes. BioFactors 2008 34 4 293 302 2-s2.0-76449106038 10.1002/biof.5520340405
19. Hasani-Ranjbar S., Nayebi N., Larijani B., Abdollahi M., A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World Journal of Gastroenterology 2009 15 25 3073 3085 2-s2.0-67651250981 10.3748/wjg.15.3073
20. Joyal S. V., A perspective on the current strategies for the treatment of obesity. Current Drug Targets 2004 3 5 341 356 2-s2.0-9144244969 10.2174/1568007043336978
21. Moon H. S., Chung C. S., Lee H. G., Kim T. G., Choi Y. J., Cho C. S., Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells. Obesity 2007 15 11 2571 2582 2-s2.0-38049030825 10.1038/oby.2007.309
22. Dunnick J. K., Kissling G., Gerken D. K., Vallant M. A., Nyska A., Cardiotoxicity of Ma Huang/caffeine or ephedrine/caffeine in a rodent model system. Toxicologic pathology 2007 35 5 657 664 2-s2.0-35748961687 10.1080/01926230701459978
23. Roberts L. D., Virtue S., Vidal-Puig A., Nicholls A. W., Griffin J. L., Metabolic phenotyping of a model of adipocyte differentiation. Physiological Genomics 2009 39 2 109 119 2-s2.0-70350337933 10.1152/physiolgenomics.90365.2008
24. Dave S., Kaur N. J., Nanduri R., Dkhar H. K., Kumar A., Gupta P., Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes. PLoS ONE 2012 7 1 2-s2.0-84856158975 10.1371/journal.pone.0030831 e30831
25. White U. A., Stephens J. M., Transcriptional factors that promote formation of white adipose tissue. Molecular and Cellular Endocrinology 2010 318 1-2 10 14 2-s2.0-76749146390 10.1016/j.mce.2009.08.023
26. MacDougald O. A., Mandrup S., Adipogenesis: forces that tip the scales. Trends in Endocrinology and Metabolism 2002 13 1 5 11 2-s2.0-0036134008 10.1016/S1043-2760(01)00517-3
27. Poulos S. P., Dodson M. V., Hausman G. J., Cell line models for differentiation: preadipocytes and adipocytes. Experimental Biology and Medicine 2010 235 10 1185 1193 2-s2.0-77957836345 10.1258/ebm.2010.010063
28. Lagace D. C., Nachtigal M. W., Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis. Journal of Biological Chemistry 2004 279 18 18851 18860 2-s2.0-2442448425 10.1074/jbc.M312795200
29. Park J. H., Lee M. J., Song M. Y., Bose S., Shin B. C., Kim H. J., Efficacy and safety of mixed oriental herbal medicines for treating human obesity: a systematic review of randomized clinical trials. Journal of Medicinal Food 2012 15 7 589 597
30. Jeon T., Hwang S. G., Hirai S., Matsui T., Yano H., Kawada T., Lim B. O., Park D. K., Red yeast rice extracts suppress adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 cells. Life Sciences 2004 75 26 3195 3203 2-s2.0-5444223557 10.1016/j.lfs.2004.06.012
31. Rosen E. D., Spiegelman B. M., Molecular regulation of adipogenesis. Annual Review of Cell and Developmental Biology 2000 16 145 171 2-s2.0-0034523640 10.1146/annurev.cellbio.16.1.145
32. Kim J. B., Spiegelman B. M., ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes and Development 1996 10 9 1096 1107 2-s2.0-0030007427
33. Park M. Y., Seo D. W., Lee J. Y., Sung M., Lee Y., Jang H., Choi H., Kim J., Park D., Effects of Panicum miliaceum L. extract on adipogenic transcription factors and fatty acid accumulation in 3T3-l1 adipocytes. Nutrition Research and Practice 2011 5 3 192 197 2-s2.0-79960833401 10.4162/nrp.2011.5.3.192
34. Morimoto C., Kameda K., Tsujita T., Okuda H., Relationships between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. Journal of Lipid Research 2001 42 1 120 127 2-s2.0-0035135884
35. Chirala S. S., Jayakumar A., Gu Z. W., Wakil S. J., Human fatty acid synthase: role of interdomain in the formation of catalytically active synthase dimer. Proceedings of the National Academy of Sciences of the United States of America 2001 98 6 3104 3108 2-s2.0-0035853039 10.1073/pnas.051635998
36. Gonzales A. M., Orlando R. A., Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutrition and Metabolism 2007 4 22 2-s2.0-37849054370 10.1186/1743-7075-4-22